• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD AFFIRM¿ VPIII AMBIENT TEMPERATURE TRANSPORT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD AFFIRM¿ VPIII AMBIENT TEMPERATURE TRANSPORT SYSTEM Back to Search Results
Catalog Number 446255
Health Effect - Clinical Codes Injury (2348); No Code Available (3191)
Date of Event 02/22/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that a technician cut their finger while using a bd affirm¿ vpiii ambient temperature transport system exposing them to bodily fluids.Injury and medical intervention were reported.
 
Additional Manufacturer Narrative
Investigation summary: bd molecular quality previously investigated an end user, affirm atts glass user injury (finger puncture) during dispense of specimen at an affirm testing facility.It was stated that the end user found glass in the specimen collection tube.Quality investigation required review of the affirm atts package insert and affirm collection poster.Per review of the affirm package insert & collection poster, it was determined that the affirm collection site was not following the affirm atts package insert or affirm collection poster instructions.The collection site was crushing the atts glass ampule (as instructed), opening the atts cap and pouring the glass into the affirm sample collection tube (not instructed).The affirm package insert and affirm collection poster does not instruct collection sites to open the atts vial and pour the glass into the collection tube.Bd has completed an update to the affirm collection poster to provide further clarification on the instructions of use with affirm atts.Bd molecular quality will continue to closely monitor for trends associated with affirm atts glass injury.Investigation conclusion: complaint not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD AFFIRM¿ VPIII AMBIENT TEMPERATURE TRANSPORT SYSTEM
Common Device Name
TRANSPORT SYSTEM
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MDR Report Key7311692
Report Number9610847-2018-00051
Device Sequence Number19294582
Product Code LIO
UDI-Device Identifier00382904462550
UDI-Public00382904462550
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K920536
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source other,user facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date10/25/2018
Device Catalogue Number446255
Device Lot Number7212779
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/25/2018
Supplement Date Received by Manufacturer02/25/2018
Initial Report FDA Received Date03/02/2018
Supplement Report FDA Received Date04/06/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-